Literature DB >> 21712052

Breast cancer screening in developing countries.

Indraneel Mittra1.   

Abstract

The incidence of breast cancer in developing countries is rapidly on the rise, and cancers are generally detected at advanced stages when a cure is not possible. If advanced cancers could be down-staged by earlier detection, many lives can be saved. However, can a screening program be successfully implemented in these countries? A high level of compliance at every level of a screening program is essential for its success. In the absence of a high level of awareness, compounded by a fatalistic attitude to life, the necessary level compliance may not be achieved. Furthermore, in view of a relatively low incidence, many women will have to be screened to detect a breast cancer; and hence a screening program may not be cost effective. It is not clear which is the best screening test to be employed; although clinical breast examination would seem appropriate, there is currently no randomized evidence that it would lead to mortality reduction. The most reasonable approach to breast cancer control in developing countries would be to provide the minimal level of cancer care that will reduce mortality and suffering, as well as to enlighten the population about the benefits of early detection using innovative approaches.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21712052     DOI: 10.1016/j.ypmed.2011.06.010

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  15 in total

1.  Diagnosis: Breast cancer screening in rural African communities.

Authors:  Renato Mariani-Costantini
Journal:  Nat Rev Clin Oncol       Date:  2013-03-12       Impact factor: 66.675

2.  White paper report of the 2011 RAD-AID Conference on International Radiology for Developing Countries: integrating multidisciplinary strategies for imaging services in the developing world.

Authors:  Kathryn L Everton; Jonathan Mazal; Daniel J Mollura
Journal:  J Am Coll Radiol       Date:  2012-07       Impact factor: 5.532

3.  Atti Le giornate della ricerca scientificae delle esperienze professionali dei giovani: Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI) Roma 20-21 dicembre 2019.

Authors: 
Journal:  J Prev Med Hyg       Date:  2020-02-13

4.  Why the time is right to tackle breast and cervical cancer in low-resource settings.

Authors:  Vivien Davis Tsu; Jose Jeronimo; Benjamin O Anderson
Journal:  Bull World Health Organ       Date:  2013-09-01       Impact factor: 9.408

5.  Constitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cells.

Authors:  Seyung S Chung; Clement Aroh; Jaydutt V Vadgama
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

6.  Organization and Evaluation of Performance Indicators of a Breast Cancer Screening Program in Meknes-Tafilalt Region, Morocco

Authors:  Hafida Charaka; Mohamed Khalis; Samira Elfakir; Youssef Chami Khazraji; Ahmed Zidouh; Loubna Abousselham; Karima El Rhazi; Badiaa Lyoussi; Chakib Nejjari
Journal:  Asian Pac J Cancer Prev       Date:  2016-12-01

7.  Socio-economic and health access determinants of breast and cervical cancer screening in low-income countries: analysis of the World Health Survey.

Authors:  Tomi F Akinyemiju
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

Review 8.  Breast cancer screening in Albania during 2007-2008.

Authors:  Aurel Kopeci; Dorina Canaku; Herion Muja; Kreshnik Petrela; Iris Mone; Gentiana Qirjako; Jolanda Hyska; Krenar Preza
Journal:  Mater Sociomed       Date:  2013-11-24

9.  Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study.

Authors:  Bugi Ratno Budiarto
Journal:  Sci Pharm       Date:  2016-02-14

10.  Morusin suppresses breast cancer cell growth in vitro and in vivo through C/EBPβ and PPARγ mediated lipoapoptosis.

Authors:  Haiyan Li; Qiaoping Wang; Lihua Dong; Chuanlan Liu; Zhen Sun; Ling Gao; Xiujie Wang
Journal:  J Exp Clin Cancer Res       Date:  2015-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.